RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Turenne Capital
T

Turenne Capital portfolio

Turenne Capital has 3 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 0.
Capital in their rounds: $153M.
Latest deal: Amolyt Pharma · Jan 6, 2023.
About this page

Its most recent investment on record is Amolyt Pharma's $140M Series B+ round in January 2023, alongside Mass General Brigham Ventures, Intermediate Capital Group, Pontifax and 6 others. By category, its portfolio leans toward Health and bio (2) and Consumer and social (1). It has co-invested with OrbiMed, Sofinnova Partners and Mass General Brigham Ventures.

What Turenne Capital invests in

How Turenne Capital invests

StageDealsCapital in rounds
Series B+ 1 50%$140M
Series A 1 50%$13M
YearDealsCapital in rounds
2020 1 50%$13M
2023 1 50%$140M

Turenne Capital portfolio companies

CompanyRound with Turenne CapitalTotal raisedLatest raise
AAmolyt Pharma
Health and bio
 Series B+ · $140M$294MJan 6, 2023
Series B+
EExotrail
Robotics and hardware
 Series A · $13M$75.1MFeb 7, 2023
Series B+
GGermitec
Health and bio
 backer$28.8MFeb 12, 2025
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Turenne Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Turenne Capital, which is a subset of its real portfolio. API: /api/v1/investors/turenne-capital (get a free API key). More: the most active VC firms and new venture capital funds.